832 INDEX
eosinophilic nasal furunculosis, 63, 115
eosinophilic plaque
atopic disease, 176, 186
clinical features,134,352,356–357
diagnostics, 353, 354, 364
pathophysiology, 351
signalment/history, 352
therapeutics, 354–355
eosinophils, 351
epidermal collarettes, 13, 23
bacterial pyoderma, 215,223, 226
sampling, 46
epidermal dysplasia, 433, 445
epidermis, 3–10
layers, 5
renewal time, 3
epidermolysis bullosa acquisita, 187
clinical features,25,64,122,192, 209
course and prognosis, 198
differential diagnosis, 193–194
etiology/pathophysiology, 189
pathologic findings, 195
signalment/history, 190
therapeutics, 197
epitheliotropic lymphoma, cutaneous (CEL),
365–370
clinical features,19,366–367,372–377
alopecia, 61,91–93
depigmentation, 65, 129
exfoliative lesions, 62,100–101,366,372–373
foot,136,592, 612
nasal planum, 67, 129
ulcerative lesions, 64, 101
d’embleeform, 367
diagnostics,54–55,368–369, 378
differential diagnosis, 367
etiology/pathophysiology, 365–366
keratinization defects, 435, 457
prognosis, 370
signalment/history, 366
therapeutics, 369–370,378–379
Eqvalan liquidseeivermectin
Ergamisolseelevamisole hydrochloride
ergocalciferol, 770
erosion, 14, 25
erosive dermatoses, 63–65
erythema ab igne, 65, 127
erythema multiforme (EM), 63,115,272–275
clinical features, 274,277–279, 281–283
feline herpes virus-associated, 712, 722
footpads, 592, 608
major, 274,282–283
minor, 274, 282
“old dog” form, 274, 275, 282
erythromycin,219,538, 771
Escherichia coli, 213
essential fatty acid supplements, 179, 438, 594, 650,
668
essential oils, 485
estradiol, serum, 340
estradiol cypionate (ECP), 771
estrogen imbalances, 60, 339,345–349
estrous related alopecia, 60
ethambutol, 515
ethyl alcohol, 149
ethyl lactate, 151, 437
etodolac, 771
EtoGesicseeetodolac
Excenelseeceftiofur
excoriations, 13, 24
adverse food reactions, 287,293, 295
atopic disease, 176,183, 186
exfoliative cutaneous lupus erythematosus
(ECLE), 469, 471
clinical features, 62, 63,105,470,477–478
prognosis, 472
exfoliative dermatoses, 62,94–105
keratinization defects, 435, 457
leishmaniasis, 460,463–464
thymoma-associatedseethymoma-associated
exfoliative dermatitis
exfoliative erythroderma
adverse drug reactions, 272, 274
differential diagnosis, 274
epitheliotropic lymphoma, 366, 367,372–373
exfoliative staphylococcal toxin, 144
exocytosis, 39
exotoxin, staphylococcal, 144facial dermatitis (dirty face syndrome) of Persian and
Himalayan cats, 62,104,435, 453
facial nerve (cranial nerve VII) deficits, 544, 557
famcyclovir,279,715, 772
famotidine, 772
fasciitis, nodularseenodular fasciitis
fatty acids
dietary deficiency, 456
essential, supplements, 179, 438, 594, 650, 668
topical therapy, 650
Feldeneseepiroxicam
feline calicivirus-associated dermatoses, 64, 712–713,
722
feline coronavirus (FcoV), 712
feline cowpox virus infection, 64, 712
feline immunodeficiency virus (FIV)-associated
dermatoses, 64,120,712,717–718
see alsoplasma cell pododermatitis, feline
feline infectious peritonitis, 712
feline leukemia virus (FeLV)-associated
dermatoses, 64, 712, 716
feline orofacial pain syndrome, 64, 713
feline papillomaviruses (FcaPV), 712
feline plasma cell pododermatitisseeplasma cell
pododermatitis, feline
feline rhinotracheitis, 712
feline sarcoma virus (FeSV), 712